Foto nga VCG<\/p>\n
Industria farmaceutike e Kin\u00ebs tani \u00ebsht\u00eb e dyta n\u00eb bot\u00eb dhe p\u00ebrb\u00ebn rreth 30 p\u00ebr qind t\u00eb totalit global p\u00ebr sa iu p\u00ebrket barnave inovative q\u00eb aktualisht jan\u00eb n\u00eb proces zhvillimi dhe k\u00ebrkimi, tha t\u00eb premten nj\u00eb zyrtar i sh\u00ebndet\u00ebsis\u00eb.<\/p>\n
Vendi ka miratuar tregtimin e 387 barnave pediatrike dhe 147 barnave p\u00ebr s\u00ebmundje t\u00eb rralla q\u00eb nga fillimi i periudh\u00ebs s\u00eb Planit t\u00eb 14-t\u00eb Pes\u00ebvje\u00e7ar (2021-2025), tha Yang Sheng, z\u00ebvend\u00ebsdrejtor i Administrat\u00ebs Komb\u00ebtare t\u00eb Produkteve Mjek\u00ebsore, n\u00eb nj\u00eb konferenc\u00eb p\u00ebr shtyp t\u00eb mbajtur nga Zyra e Informacionit t\u00eb K\u00ebshillit t\u00eb Shtetit, citon \u201cXinhua\u201d.<\/p>\n
Yang theksoi masat gjith\u00ebp\u00ebrfshir\u00ebse t\u00eb Kin\u00ebs p\u00ebr t\u00eb sigurin\u00eb e barnave, p\u00ebr t\u00eb promovuar zhvillimin e industris\u00eb farmaceutike dhe p\u00ebr t\u00eb p\u00ebrmbushur nevojat publike p\u00ebr ila\u00e7e gjat\u00eb periudh\u00ebs s\u00eb Planit t\u00eb 14-t\u00eb Pes\u00ebvje\u00e7ar.<\/p>\n